Getein Biotech, Inc (SHA:603387)

Getein Biotech Revenue

Getein Biotech had revenue of 264.82M CNY in the quarter ending September 30, 2026, with 8.09% growth. This brings the company's total for the last twelve months to 1.11B, up 6.86% year-over-year. In the year 2025, Getein Biotech had annual revenue of 1.05B, down -9.71%. That makes Getein Biotech the 18,793rd largest company in the world by revenue and 3,444th in China.

• Revenue (ttm): 1.11B
• Revenue Growth: +6.86%
• P/S Ratio: 3.75
• Revenue / Employee: 642.92K
• Employees: 1,733
• Market Cap: 4.17B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 868.15M 82.5%
• Foreign 183.56M 17.5%

Fiscal year ended Dec 31, 2025 See the full Getein Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.05B	-113.08M	-9.71%
Dec 31, 2024	1.16B	-204.36M	-14.93%
Dec 31, 2023	1.37B	-452.70M	-24.85%
Dec 31, 2022	1.82B	420.16M	29.97%
Dec 31, 2021	1.40B	278.37M	24.78%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 14, 2026

Data Sources Report a data error